Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Dev Growth Differ. 2021 Feb;63(2):154-165. doi: 10.1111/dgd.12719.
This paper overviews the development and differentiation of the hypothalamus and pituitary gland from embryonic stem (ES) and induced pluripotent stem (iPS) cells. It is important to replicate the developmental process in vivo to create specific cells/organoids from ES/iPS cells. We also introduce the latest findings and discuss future issues for clinical application. Neuroectodermal progenitors are induced from pluripotent stem cells by strictly removing exogenous patterning factors during the early differentiation period. The induced progenitors differentiate into rostral hypothalamic neurons, in particular magnocellular vasopressin neurons. In three-dimensional cultures, ES/iPS cells differentiate into hypothalamic neuroectoderm and nonneural head ectoderm adjacently. Rathke's pouch-like structures self-organize at the interface between the two layers and generate various endocrine cells, including corticotrophs and somatotrophs. Our next objective is to sophisticate our stepwise methodology to establish a novel transplantation treatment for hypopituitarism and apply it to developmental disease models.
本文综述了胚胎干细胞(ES)和诱导多能干细胞(iPS)向下丘脑和垂体发育和分化。重要的是要复制体内的发育过程,从而从 ES/iPS 细胞中创建特定的细胞/类器官。我们还介绍了最新的发现,并讨论了未来的临床应用问题。神经外胚层祖细胞通过在早期分化期严格去除外源模式形成因子,从多能干细胞中诱导产生。诱导产生的祖细胞分化为前脑下丘脑神经元,特别是大细胞加压素神经元。在三维培养中,ES/iPS 细胞分化为下丘脑神经外胚层和邻近的非神经头部外胚层。Rathke 囊样结构在两层之间的界面处自组织,并产生各种内分泌细胞,包括促肾上腺皮质激素细胞和生长激素细胞。我们的下一个目标是完善我们的逐步方法,为垂体功能减退症建立一种新的移植治疗方法,并将其应用于发育性疾病模型。